Remdesivir improved majority of patients hospitalized with severe COVID-19
by Press Release from Outbreak News Today on (#528ZC)
Nearly two thirds of severely ill patients hospitalized with COVID-19 who received remdesivir on a compassionate-use basis improved, with no new concerns about safety reported during the short clinical study. That's the preliminary results of the first clinical trial of the promising antiviral therapy remdesivir conducted at UC Davis Health and other hospitals in the ["]
The post Remdesivir improved majority of patients hospitalized with severe COVID-19 appeared first on Outbreak News Today.